Clinical Trials Browser

Neurofibromatosis 2 × Sirolimus × CNS × Clear all

NCT01552434 2025-10-14

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

BreastCNSGenitourinaryHead & NeckLymphoidMyeloidSarcoma

Breast Neoplasms, Carcinoma, Transitional Cell, Endocrine Gland Neoplasms, Castleman Disease, Mouth Neoplasms, Neoplasm Metastasis, Neoplasms, Pharyngeal Neoplasms, Recurrence, Sarcoma, Soft Tissue Neoplasms, Thyroid Neoplasms, Urologic Neoplasms, Neurofibromatosis 2, Lymphangioleiomyomatosis, Neoplasms, Mesothelial, Erdheim-Chester Disease

NCT01490476 2017-05-23

AFINF2

Phase 2 Completed

10 enrolled

CNS

Vestibulocochlear Nerve Diseases, Neuroma, Acoustic, Otorhinolaryngologic Diseases, Peripheral Nervous System Diseases, Neurofibromatosis 2